Dompe Farmaceutici`s Biologic Oxervate (cenegermin) Receives Approval in the U.S.
MILAN & CHARLOTTE, N.C.--(BUSINESS WIRE)--Dompé farmaceutici S.p.A. (“Dompé”) and Tanner Pharma Group, Inc. today announced they have entered into an agreement whereby Tanner Pharma Group will become Dompé’s exclusive distribution partner for Oxervate (cenegermin) in selected countries.